Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Diabetic Nephropathy Treatment Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising global prevalence of diabetes with increasing geriatric population
5.1.1.2. Government-led initiatives to address the burden of diabetes and its complications
5.1.1.3. Growing emphasis on patient-centric care plans for diabetic nephropathy
5.1.2. Restraints
5.1.2.1. High cost of diabetic nephropathy treatments
5.1.3. Opportunities
5.1.3.1. Introduction of new and more effective diabetic nephropathy treatments
5.1.3.2. Improved reimbursement policies and healthcare coverage for diabetic nephropathy treatments
5.1.4. Challenges
5.1.4.1. Comorbidities and complexity of care associated with diabetic nephropathy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Diabetic Nephropathy Treatment Market, by Treatment Type
6.1. Introduction
6.2. End-stage Renal Disease (ESRD) Treatment
6.3.1. Kidney Dialysis
6.3.2. Transplant
6.3. Medications
6.4.1. Angiotensin 2 Receptor Blockers (ARBs)
6.4.2. Angiotensin-converting Enzyme (ACE) Inhibitors
6.4.3. Cholesterol-lowering Drugs
6.4.4. Metformin
6.4. Pharmacological Treatment

7. Diabetic Nephropathy Treatment Market, by End-User
7.1. Introduction
7.2. Hospitals
7.3. Nephrology Clinics

8. Americas Diabetic Nephropathy Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Diabetic Nephropathy Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Diabetic Nephropathy Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. AbbVie Inc.
12.1.3. Amgen Inc.
12.1.4. AstraZeneca PLC
12.1.5. Aurobindo Pharma Limited
12.1.6. Bayer AG
12.1.7. Boehringer Ingelheim International GmbH
12.1.8. Bristol-Myers Squibb Company
12.1.9. ChemoCentryx, Inc.
12.1.10. Daiichi Sankyo Company, Limited
12.1.11. Dr. Reddy’s Laboratories Ltd.
12.1.12. Eli Lilly and Company
12.1.13. Endo International PLC
12.1.14. IQVIA Inc.
12.1.15. Johnson & Johnson Services, Inc.
12.1.16. Mallinckrodt Pharmaceuticals
12.1.17. Merck & Co., Inc.
12.1.18. Mesoblast Ltd
12.1.19. Novartis AG
12.1.20. Otsuka Pharmaceutical Co., Ltd.
12.1.21. Pfizer, Inc.
12.1.22. Reata Pharmaceuticals, Inc.
12.1.23. Sanofi SA
12.1.24. Sun Pharmaceutical Industries Ltd.
12.1.25. Teva Pharmaceutical Industries Ltd.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. DIABETIC NEPHROPATHY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DIABETIC NEPHROPATHY TREATMENT MARKET DYNAMICS
FIGURE 7. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. DIABETIC NEPHROPATHY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. DIABETIC NEPHROPATHY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. DIABETIC NEPHROPATHY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY KIDNEY DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 12. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY ANGIOTENSIN 2 RECEPTOR BLOCKERS (ARBS), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY CHOLESTEROL-LOWERING DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY METFORMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY NEPHROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. CANADA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 36. CANADA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. MEXICO DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 40. MEXICO DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. CHINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 58. CHINA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. INDIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 62. INDIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. JAPAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 70. JAPAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. THAILAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 94. THAILAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. DENMARK DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 107. DENMARK DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. EGYPT DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. EGYPT DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. FINLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 115. FINLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. GERMANY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. ITALY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 131. ITALY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. NORWAY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 143. NORWAY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. POLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 147. POLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. QATAR DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 151. QATAR DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 179. TURKEY DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-STAGE RENAL DISEASE (ESRD) TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DIABETIC NEPHROPATHY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. DIABETIC NEPHROPATHY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. DIABETIC NEPHROPATHY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. DIABETIC NEPHROPATHY TREATMENT MARKET LICENSE & PRICING